Estamos no ar no ! Saiba mais
ícone de KTTAW

Pasithea Therapeutics Warrants
KTTAW

Deslistada

KTTAW foi retirado da bolsa em 15 de setembro de 2026.

 

Sobre: Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

Funcionários: 5

Notícias

Positiva
Neutra
Negativa
Sentimento 3 meses
Positiva 0%
Neutra 0%
Negativa 0%

Não recebemos notícias recentes sobre KTTAW

Gráficos de preços implementados com Lightweight Charts™